TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD

QQQ $ 605.83 $ 1.98 (0.33 %)

DIA $ 465.50 $ 0.82 (0.18 %)

SPY $ 668.65 $ 1.86 (0.28 %)

TLT $ 91.14 $ 0.16 (0.18 %)

GLD $ 386.38 $ 0.40 (0.1 %)

Previous Close

$ 20.11

Open

$ 19.93

Bid

$ 19.86 x 300

Ask

$ 19.88 x 500

Day's Range

$ 19.75 - $ 20.02

52 Week Range

$ 12.47 - $ 22.80

Volume

6,550,555

Average Volume

Market Cap

23.07B

Beta (5Y Monthly)

$ 0.92

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	07-30-2025	06-30-2025	10-Q
2	05-07-2025	03-31-2025	10-Q
3	02-05-2025	12-31-2024	10-K
4	11-06-2024	09-30-2024	10-Q
5	07-31-2024	06-30-2024	10-Q
6	05-08-2024	03-31-2024	10-Q
7	02-12-2024	12-31-2023	10-K
8	11-09-2023	09-30-2023	10-Q
9	08-02-2023	06-30-2023	10-Q
10	05-10-2023	03-31-2023	10-Q
11	02-10-2023	12-31-2022	10-K
12	11-03-2022	09-30-2022	10-Q
13	07-27-2022	06-30-2022	10-Q
14	05-03-2022	03-31-2022	10-Q
15	02-09-2022	12-31-2021	10-K
16	10-27-2021	09-30-2021	10-Q
17	07-28-2021	06-30-2021	10-Q
18	04-28-2021	03-31-2021	10-Q
19	02-10-2021	12-31-2020	10-K
20	11-05-2020	09-30-2020	10-Q
21	08-05-2020	06-30-2020	10-Q
22	05-07-2020	03-31-2020	10-Q
23	02-21-2020	12-31-2019	10-K
24	11-07-2019	09-30-2019	10-Q
25	08-07-2019	06-30-2019	10-Q
26	05-02-2019	03-31-2019	10-Q
27	02-19-2019	12-31-2018	10-K
28	11-01-2018	09-30-2018	10-Q
29	08-02-2018	06-30-2018	10-Q
30	05-03-2018	03-31-2018	10-Q
31	02-12-2018	12-31-2017	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

scisparc-expands-biotech-ambitions-buys-stake-in-miza-iii-ventures

SciSparc Expands Biotech Ambitions, Buys S...
10/15/2025 13:34:30

SciSparc traded higher after the company announced it had signed a definitive agreement to acquire a controlling stake in Miza ...

Teva Pharmaceuticals Announces FDA Approve...
10/10/2025 19:01:29

FDA approves UZEDY® (risperidone) extended-release injectable suspension for subcutaneous use as monotherapy or as adjunctive t...

teva-viatris-on-investor-watch-as-white-house-spares-generic-drugs-from-tariffs

Teva, Viatris On Investor Watch As White H...
10/09/2025 13:31:09

The Trump administration backs off plans to impose tariffs on generic drugs after internal debate over price impacts and supply...

SciSparc And AutoMax Call Off Merger
10/06/2025 12:55:03

SciSparc ends merger with AutoMax, sets loan repayment terms, and refocuses on CNS drug development and innovation.

JP Morgan Maintains Overweight on Teva Pha...
10/03/2025 12:21:58

JP Morgan analyst Chris Schott maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Overweight and raises the price target...

Is Teva Pharmaceutical Indus Gaining or Lo...
09/24/2025 13:00:41

UBS Maintains Buy on Teva Pharmaceutical I...
09/24/2025 12:53:54

UBS analyst Ashwani Verma maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Buy and raises the price target from $23 to...

FDA Chief Says Leucovorin Will Be Made Ava...
09/22/2025 21:20:40

https://www.youtube.com/watch?v=esKFMCb_hYUhttps://www.youtube.com/watch?v=esKFMCb_hYU

Reported Saturday, Teva Announces Long Ter...
09/22/2025 06:53:23

Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) eve...

Reported Saturday, Teva Reports Patients W...
09/22/2025 06:50:12

Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AU...

trump-administration-to-unveil-tylenol-autism-review-tout-this-drug-as-potential-treatment-report

Trump Administration To Unveil Tylenol-Aut...
09/22/2025 05:36:39

Trump administration to announce concerns about Tylenol use in pregnancy and potential treatment for autism, in line with Presi...

Teva To Hold Conference Call To Discuss Ph...
09/16/2025 20:31:20

FDA Grants Teva Pharmaceutical's Emrusolmi...
09/09/2025 12:31:56

Teva received Fast Track designation from the U.S. Food and Drug Administration for emrusolmin (TEV-56286), an investigational ...

teva-launches-generic-glp-1-weight-loss-drug-with-fda-nod-for-saxenda

Teva Launches Generic GLP-1 Weight Loss Dr...
08/28/2025 18:58:18

Teva launches the first U.S. generic version of Saxenda for weight loss after FDA approval, expanding its portfolio with a key ...

Teva Announces FDA Approval Of Generic Ver...
08/28/2025 12:35:06

10 Health Care Stocks With Whale Alerts In...
08/21/2025 17:35:27

How Is The Market Feeling About Teva Pharm...
08/18/2025 15:00:30

The FDA Approves Teva Pharmaceuticals' Ajo...
08/06/2025 11:21:58

teva-pharma-boosts-outlook-for-key-innovative-drugs-austedo-ajovy-uzedy

Teva Pharma Boosts Outlook For Key Innovat...
07/30/2025 17:15:45

Teva raised 2025 guidance for Austedo, Ajovy, and Uzedy after Q2 earnings beat estimates, despite missing revenue expectations.

During Conf Call, Teva Pharmaceuticals CEO...
07/30/2025 13:46:18